Global Carbapenem Antibiotics Market Growth 2023-2029

Global Carbapenem Antibiotics Market Growth 2023-2029

LPI (LP Information)' newest research report, the “Carbapenem Antibiotics Industry Forecast” looks at past sales and reviews total world Carbapenem Antibiotics sales in 2022, providing a comprehensive analysis by region and market sector of projected Carbapenem Antibiotics sales for 2023 through 2029. With Carbapenem Antibiotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Carbapenem Antibiotics industry.

This Insight Report provides a comprehensive analysis of the global Carbapenem Antibiotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Carbapenem Antibiotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Carbapenem Antibiotics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Carbapenem Antibiotics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Carbapenem Antibiotics.

The global Carbapenem Antibiotics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Carbapenem Antibiotics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Carbapenem Antibiotics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Carbapenem Antibiotics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Carbapenem Antibiotics players cover ACS Dobfar S.p.A, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL CO.,LTD, Aurobindo Pharma Ltd, Gland Pharma Limited, Merck & Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Savior Lifetec and Pfizer Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Carbapenem Antibiotics market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Meropenem
Donipenem
Imipenem
Tipipenem
Others

Segmentation by application
Retail Pharmacy
Online Pharmacy
Hospital Pharmacy

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ACS Dobfar S.p.A
Iterum Therapeutics plc
DAEWOONG PHARMACEUTICAL CO.,LTD
Aurobindo Pharma Ltd
Gland Pharma Limited
Merck & Co., Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Savior Lifetec
Pfizer Inc.
Spero Therapeutics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Carbapenem Antibiotics market?

What factors are driving Carbapenem Antibiotics market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Carbapenem Antibiotics market opportunities vary by end market size?

How does Carbapenem Antibiotics break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.